Top Biotech Companies (3,713)
ENPICOM develops high-performance bioinformatics software and services for biotech and pharmaceutical scientists. Its platform transforms immune-repertoire data into actionable insights for therapeutic and antibody discovery, integrating computational science, immunology, machine learning, and software engineering. The company connects wet-lab and dry-lab workflows, automates analysis, and supports data-driven decisions to accelerate biologics discovery, development, and identification of better drug candidates across modern...
Flourish Research is a fully integrated clinical trial organization in North America. We acquire and operate large, best-in-class sites with the very best medical and scientific expertise, meaningful diversity, and reliable recruitment. The Flourish Difference: Meaningful Diversity - We constantly innovate our approach to support diversity in our patient populations and employees. Exceptional Scale and Agility - By acquiring and operating some of...
BioLM is a SaaS and professional services company that helps biotech and life science companies accelerate their adoption of AI. They provide an API layer for biological language models, allowing researchers to program DNA and proteins like software. Their mission is to accelerate biologics development through data-driven AI and human expertise, offering a platform for the full protein design stack...
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of...
Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about...
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval...
GeneFab is a contract development, manufacturing, and synthetic biology biofoundry focused on cell and gene therapies. The company bridges innovation and manufacturing with end-to-end biotechnology services, combining computational design and data analysis with cGMP-compliant production to advance genetic medicines from concept to clinic, partnering with innovators to deliver life-changing therapies to patients in need.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
HALO Precision Diagnostics™ changes patient lives and outcomes through early detection of the leading causes of death with precision diagnostics. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkers, and community-based data at scale combined with deep learning algorithms. By optimizing all these solutions under the HALO Diagnostics platform, we provide rapid, precise, actionable...
Imricor Medical Systems develops magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias.
Tr1X Inc. (pr. "Trix") is a biotechnology company dedicated to the development of novel cellular immunotherapies for patients with autoimmune and inflammatory diseases. The Company uses its proprietary platform for the generation of first-in-class cell therapy products aimed at rebalancing the immune system and restoring homeostasis, leading to long term tolerance. Tr1X is headquartered in La Jolla, CA.
Mosaic Biosciences transforms concepts into drug candidates with end-to-end discovery capabilities and a first-class multidisciplinary team. We provide experienced biopharma leadership and cross-functional teams to accelerate your protein therapeutic research and development program.
We are hiring: https://histowiz.workable.com/ About HistoWiz HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among medical scientists and research pathologists. HistoWiz's mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for...
We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company’s unique performance enzymes...
Founded in 1974, EMBL is Europe’s flagship laboratory for the life sciences – an intergovernmental organisation with more than 80 independent research groups covering the spectrum of molecular biology. It operates across six sites: Heidelberg, Barcelona, Hamburg, Grenoble, Rome and EMBL-EBI Hinxton. www.embl.org | www.embl.org/jobs Our mission is to perform basic research in molecular biology; to offer vital services to scientists...
Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and...
Novozymes's Top Stability & Growth Strengths
Strong Market Position & Advantage: The combined company is repeatedly characterized as the category leader in industrial enzymes and a top player in biosolutions, supported by scale, application know‑how, and embedded customer relationships. Its extensive portfolio and broad global presence across many industries reinforce durable competitive advantage.
Strong Revenue Growth: Company communications highlight consistent organic sales growth across 2024–2026 updates, with momentum evident in both developed and emerging markets. Growth appears broad‑based across segments such as Food & Health and Planetary/industrial applications.
Innovation-Driven Growth: A sustained commitment to R&D, frequent new biosolution launches, and a sizable patent estate underpin product vitality and extension into adjacent domains like human health and bioagriculture. Partnerships and technology leadership (e.g., advanced enzyme applications) support continued pipeline-driven expansion.
Galatea Bio is an innovative, venture-backed biotechnology company dedicated to advancing precision health for all. The company leverages world-class ancestry algorithms to better understand underserved Latin American populations while maintaining a strong commitment to ethical research. It partners with pharmaceutical and life sciences organizations to design and execute projects that utilize human genetic diversity to solve acute problems in biomedicine.
Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro is advancing a robust early-stage pipeline of novel exatecan and dual-payload antibody drug conjugates (ADCs), coupled with...
INFORS HT is a Swiss biotechnology and laboratory-equipment company that develops, manufactures, and maintains incubator shakers and bioreactors for research and bioprocessing. Its portfolio also includes bioprocess platform software, custom-built equipment, and related services. The company supports reproducible cultivation of microorganisms and cell lines across applications such as fermentation, cell culture, biofuels, and parallel bioprocessing for research teams across the...

































